Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
62
MXCHY Quote, Financials, Valuation and Earnings
Last price:
$2.37
Seasonality move
:
-0.04%
Day range:
$2.27 - $2.38
52-week range:
$1.00 - $2.38
Dividend yield:
0%
P/E ratio:
7.11x
P/S ratio:
0.30x
P/B ratio:
0.98x
Volume:
10.7K
Avg. volume:
12.6K
1-year change:
88.84%
Market cap:
$2.3B
Revenue:
$7.5B
EPS (TTM):
-$0.38
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Orbia Advance Corp. SAB de CV has 140.51% upside to fair value with a price target of -- per share.
MXCHY vs. S&P 500
-
Over the past 5 trading days, Orbia Advance Corp. SAB de CV has overperformed the S&P 500 by 14.6% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Orbia Advance Corp. SAB de CV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Orbia Advance Corp. SAB de CV has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Orbia Advance Corp. SAB de CV reported revenues of $2B.
Earnings Growth
-
Orbia Advance Corp. SAB de CV earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Orbia Advance Corp. SAB de CV reported earnings per share of -$0.13.
Enterprise value:
7.7B
EV / Invested capital:
--
Price / LTM sales:
0.30x
EV / EBIT:
19.54x
EV / Revenue:
1.02x
PEG ratio (5yr expected):
0.06x
EV / Free cash flow:
46.01x
Price / Operating cash flow:
13.56x
Enterprise value / EBITDA:
7.21x
Gross Profit (TTM):
$1.6B
Return On Assets:
-2.47%
Net Income Margin (TTM):
-3.74%
Return On Equity:
-9.39%
Return On Invested Capital:
-3.24%
Operating Margin:
6.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $8.5B | $7.5B | $7.5B | $1.9B | $2B | |
| Gross Profit | $2.3B | $1.7B | $1.6B | $430M | $433.6M | |
| Operating Income | $983M | $514M | $393.1M | $140M | $123.2M | |
| EBITDA | $1.6B | $1.6B | $1.1B | $304M | $288.4M | |
| Diluted EPS | $0.10 | $0.14 | -$0.38 | $0.09 | -$0.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.6B | $4.2B | $4.5B | $3.9B | $4.1B | |
| Total Assets | $10.5B | $11.1B | $11.6B | $11.5B | $11.4B | |
| Current Liabilities | $2.6B | $3B | $2.7B | $2.6B | $2.6B | |
| Total Liabilities | $7.1B | $7.9B | $8.4B | $8.3B | $8.6B | |
| Total Equity | $3.3B | $3.2B | $3.3B | $3.2B | $2.8B | |
| Total Debt | $4.3B | $4.4B | $5.1B | $5.2B | $5.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $594M | $578.8M | $299M | $308.9M | |
| Cash From Investing | -$698.5M | -$576M | -$378.2M | -$142M | -$132.4M | |
| Cash From Financing | $89.8M | -$569M | -$77.8M | -$39M | -$45.1M | |
| Free Cash Flow | $441.6M | $47M | $167M | $195M | $222.7M | |
MXCHY
Sector
Market Cap
$2.3B
--
Price % of 52-Week High
99.58%
--
Dividend Yield
0%
--
Shareholder Yield
3.91%
--
1-Year Price Total Return
88.85%
--
Beta (5-Year)
0.600
--
Dividend yield:
0%
Annualized payout:
$0.17
Payout ratio:
95.05%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.14
200-day SMA
Buy
Level
$1.61
Bollinger Bands (100)
Buy
Level
1.68 - 1.98
Chaikin Money Flow
Sell
Level
-12.4K
20-day SMA
Buy
Level
$2.02
Relative Strength Index (RSI14)
Buy
Level
71.45
ADX Line
Buy
Level
18.14
Williams %R
Sell
Level
-2.1978
50-day SMA
Buy
Level
$1.86
MACD (12, 26)
Buy
Level
0.60
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
70.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0883)
Sell
CA Score
(Annual)
Level (-1.1455)
Buy
Beneish M-Score
(Annual)
Level (-2.5082)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (0.6306)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Orbia Advance Corp. SAB de CV engages in the manufacture and sale of petrochemical products. It operates through the following segments: Vinyl, Fluor and Fluent. The Vinyl segment offers treatment and purifies water. The Fluor segment operates through three segments: Fluoride Process, Hydrofluoric Acid and Aluminium Fluoride Process and Refrigerant Gas Process. The Fluoride Process segment extracts fluorite, which is used in the production of hydrofluoric acid, the cement, ceramic, steel and welding industries. The Fluent segment manufactures products for day to day purposes like PVC pipes and connections, polyethene and polypropylene, as well as geosynthectics, which are used for water management systems. The company was founded in 1953 and is headquartered in Mexico City, Mexico.
Stock Forecast FAQ
In the current month, MXCHY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MXCHY average analyst price target in the past 3 months is --.
-
Where Will Orbia Advance Corp. SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Orbia Advance Corp. SAB de CV share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Orbia Advance Corp. SAB de CV?
Analysts are divided on their view about Orbia Advance Corp. SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Orbia Advance Corp. SAB de CV is a Sell and believe this share price will drop from its current level to --.
-
What Is Orbia Advance Corp. SAB de CV's Price Target?
The price target for Orbia Advance Corp. SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MXCHY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Orbia Advance Corp. SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MXCHY?
You can purchase shares of Orbia Advance Corp. SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Orbia Advance Corp. SAB de CV shares.
-
What Is The Orbia Advance Corp. SAB de CV Share Price Today?
Orbia Advance Corp. SAB de CV was last trading at $2.37 per share. This represents the most recent stock quote for Orbia Advance Corp. SAB de CV. Yesterday, Orbia Advance Corp. SAB de CV closed at $2.37 per share.
-
How To Buy Orbia Advance Corp. SAB de CV Stock Online?
In order to purchase Orbia Advance Corp. SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MXCHY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MXCHY
Sector
P/E ratio
7.11x
--
PEG ratio
0.06x
--
P/B ratio
0.98x
--
Price / LTM sales
0.30x
--
Growth Metrics
MXCHY
Sector
Revenue growth
4.34%
--
Earnings growth
-239.25%
--
Revenue (5-year growth)
1.36%
--
Earnings forecast
--
--
Profitability
MXCHY
Sector
Profitability FY 2024
$1.5B
--
Return on invested capital
-3.24%
--
Return on assets
-2.47%
--
Return on equity
-9.39%
--
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Jan
21
Balance Sheet
MXCHY
Sector
Total cash
$991M
--
Short term investments
$1M
--
Total assets
$11.1B
--
Long term debt
$5.5B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
